Cargando…
Recombinant immunotoxins development for HER2-based targeted cancer therapies
Understanding the molecular mechanisms of cancer biology introduces targeted therapy as a complementary method along with other conventional therapies. Recombinant immunotoxins are tumor specific antibodies that their recognizing fragment is utilized for delivering modified toxins into tumor cells....
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422749/ https://www.ncbi.nlm.nih.gov/pubmed/34488747 http://dx.doi.org/10.1186/s12935-021-02182-6 |